Skip to main content

Table 3 The Odds ratio for the prevalence of CKD in patients with or without T2DM

From: The association of metabolic syndrome components and chronic kidney disease in patients with hypertension

 

Model 1

Model 2

Model 3

 

OR (95% CI)

p

OR (95% CI)

p

OR (95% CI)

p

Diabetes (+)

Hypertension grades

1.37 (1.12–1.68)

< 0.01

1.38 (1.13–1.69)

< 0.01

1.37 (1.04–1.82)

0.03

Elevated TG

1.79 (1.12–2.87)

0.02

1.95 (1.21–3.15)

0.01

2.10 (1.22–3.61)

0.01

Reduced HDL-C

0.81 (0.51–1.29)

0.37

0.79 (0.49–1.27)

0.33

0.66 (0.39–1.13)

0.13

Elevated waist circumference

1.43 (0.97–2.09)

0.07

1.47 (1.00–2.17)

0.05

1.28 (0.74–2.20)

0.37

Diabetes (−)

Hypertension grades

1.03 (0.91–1.17)

0.64

1.08 (0.95–1.23)

0.23

1.03 (0.85–1.24)

0.79

Elevated TG

1.35 (0.99–1.82)

0.06

1.54 (1.12–2.12)

0.01

1.53 (1.09–2.16)

0.01

Reduced HDL-C

1.29 (0.94–1.76)

0.12

1.23 (0.89–1.71)

0.21

1.18 (0.83–1.68)

0.37

Elevated waist circumference

1.30 (1.03–1.63)

0.03

1.18 (0.93–1.49)

0.17

1.00 (0.70–1.40)

0.98

  1. Model 1: unadjusted OR; Model 2: OR adjusted for age and gender; Model 3: OR adjusted for age, gender, antihypertensive therapy and statin therapy. DM: Diabetes mellitus; FBG: Fasting blood glucose; HDL-C: High density lipoprotein-C; TG: Triglycerides